Miguel Cendoroglo Neto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Miguel Cendoroglo Neto has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Camila Sardenberg
Department of Medicine, Division of Nephrology, Universidade Federal de São Paulo-UNIFESP, São Paulo, São Paulo, Brazil
2 shared publicationsMaria Aparecida Dalboni
Department of Medicine, Division of Nephrology, Universidade Federal de São Paulo—UNIFESP, São Paulo, São Paulo, Brazil
2 shared publicationsRenato Watanabe
Department of Medicine, Division of Nephrology, Universidade Federal de São Paulo—UNIFESP, São Paulo, São Paulo, Brazil
2 shared publicationsBento F.C. dos Santos
Division of Nephrology, Department of Medicine, Universidade Federal de São Paulo—UNIFESP, São Paulo, SP, Brazil; and
1 shared publicationBertrand Jaber
Division of Nephrology, Department of Medicine, New England Medical Center, Boston, MassachusettsUSA
1 shared publicationBertrand L. Jaber
Division of Nephrology, Department of Medicine, New England Medical Center Hospital, Boston, MA, U.S.A.
1 shared publication
Latest Publications
- Open Access
- 20 February 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 43
Impact of acute kidney injury exposure period among liver transplantation patients
Background: Acute kidney injury is a common complication of liver transplantation. In this single-centre retrospective observational study, we investigated the impact of acute kidney disease on liver recipient survival. Methods: The study population consisted of patients who underwent a liver engraftment between January 2002 and November 2006, at a single transplantation centre in São Paulo, Brazil. Acute kidney injury diagnosis and staging were according to the recommendations of the Acute Kidney Injury Network and consisted of scanning the daily serum creatinine levels throughout the hospital stay. Patients requiring renal replacement therapy prior to transplantation, those who developed acute kidney injury before the procedure or those receiving their second liver graft were excluded from the study. Results: A total of 444 liver transplantations were performed during the study period, and 129 procedures (29%) were excluded. The remaining 315 patients constituted the study population. In 207 procedures, the recipient was male (65%). The mean age of the population was 51 years. Cumulative incidence of acute kidney injury within 48 h, during the first week after transplantation, and throughout the hospital stay was 32, 81 and 93%, respectively. Renal replacement therapy was required within a week after the transplantation in 31 procedures (10%), and another 17 (5%) required replacement therapy after that period. Mean follow-up period was 2.3 years. Time in days from acute kidney injury diagnosis to initiation of replacement therapy or reaching serum creatinine peak was associated with lower overall survival even when adjusted for significant potential confounders (HR 1.03; 95% CI 1.01, 1.05; p=0.002). Overall, patients experiencing acute kidney injury lasting for a week or more before initiation of replacement therapy experienced a threefold increase in risk of death (HR 3.02; 95% CI 2.04, 4.46; p<0.001). Conclusions: Acute kidney injury after liver transplantation is remarkably frequent and has a substantial impact on patient survival. Delaying the initiation of renal replacement therapy in such population may increase mortality by more than 20% per day.
- 20 February 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 43
Open AccessImpact of acute kidney injury exposure period among liver transplantation patients
Background: Acute kidney injury is a common complication of liver transplantation. In this single-centre retrospective observational study, we investigated the impact of acute kidney disease on liver recipient survival. Methods: The study population consisted of patients who underwent a liver engraftment between January 2002 and November 2006, at a single transplantation centre in São Paulo, Brazil. Acute kidney injury diagnosis and staging were according to the recommendations of the Acute Kidney Injury Network and consisted of scanning the daily serum creatinine levels throughout the hospital stay. Patients requiring renal replacement therapy prior to transplantation, those who developed acute kidney injury before the procedure or those receiving their second liver graft were excluded from the study. Results: A total of 444 liver transplantations were performed during the study period, and 129 procedures (29%) were excluded. The remaining 315 patients constituted the study population. In 207 procedures, the recipient was male (65%). The mean age of the population was 51 years. Cumulative incidence of acute kidney injury within 48 h, during the first week after transplantation, and throughout the hospital stay was 32, 81 and 93%, respectively. Renal replacement therapy was required within a week after the transplantation in 31 procedures (10%), and another 17 (5%) required replacement therapy after that period. Mean follow-up period was 2.3 years. Time in days from acute kidney injury diagnosis to initiation of replacement therapy or reaching serum creatinine peak was associated with lower overall survival even when adjusted for significant potential confounders (HR 1.03; 95% CI 1.01, 1.05; p=0.002). Overall, patients experiencing acute kidney injury lasting for a week or more before initiation of replacement therapy experienced a threefold increase in risk of death (HR 3.02; 95% CI 2.04, 4.46; p<0.001). Conclusions: Acute kidney injury after liver transplantation is remarkably frequent and has a substantial impact on patient survival. Delaying the initiation of renal replacement therapy in such population may increase mortality by more than 20% per day.
- 1 January 2004
- Published by Taylor & Francis in Renal Failure
- Vol. 26 (6) , 673-681
Balance Between Cytokine Production by Peripheral Blood Mononuclear Cells and Reactive Oxygen Species Production by Monocytes in Patients with Chronic Kidney Disease
Hemodialysis (HD) and peritoneal dialysis are associated with inflammatory events and immunological incompetence. The purpose of this study was to evaluate the effect of both uremia and dialysis mo...
- 1 January 2004
- Published by Taylor & Francis in Renal Failure
- Vol. 26 (6) , 673-681
Balance Between Cytokine Production by Peripheral Blood Mononuclear Cells and Reactive Oxygen Species Production by Monocytes in Patients with Chronic Kidney Disease
Hemodialysis (HD) and peritoneal dialysis are associated with inflammatory events and immunological incompetence. The purpose of this study was to evaluate the effect of both uremia and dialysis mo...
- 13 August 2003
- Published by Wiley in Artificial Organs
- Vol. 27 (8) , 687-691
Soluble Fas: A Novel Marker of Inflammation in Uremia
Background: Inflammation has been associated with atherosclerotic cardiovascular disease (CVD) and anemia in patients with end‐stage renal disease (ESRD). Recent studies have shown that se...
- 13 August 2003
- Published by Wiley in Artificial Organs
- Vol. 27 (8) , 687-691
Soluble Fas: A Novel Marker of Inflammation in Uremia
Background: Inflammation has been associated with atherosclerotic cardiovascular disease (CVD) and anemia in patients with end‐stage renal disease (ESRD). Recent studies have shown that se...